New Economic Study: Dapagliflozin Cost-Effective in Kidney Disease ...Middle East

Medscape - News
Dapagliflozin is cost-effective for chronic kidney disease compared with standard of care, in the UK, Germany, and Spain, despite the fact that the drug has high acquisition costs, finds a new analysis. Medscape Medical News

Hence then, the article about new economic study dapagliflozin cost effective in kidney disease was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( New Economic Study: Dapagliflozin Cost-Effective in Kidney Disease )

Apple Storegoogle play

Last updated :

Also on site :